February 06, 2020
PharMerica Corp. must face False Claims Act allegations it defrauded Medicare and Medicaid by billing for prescriptions with illegally altered dosages and that it retaliated against a whistleblowing former executive by coordinating a campaign to discredit her, a Pennsylvania federal judge ruled.